top of page
Home
Team
Portfolio
Blog
Contact
Investors
MCPF I
MCPF II
Opportunity Fund
MCPF III
MCPF IV
More
Use tab to navigate through the menu items.
Our Recent Posts
OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing
Archive
December 2024
(1)
1 post
October 2024
(1)
1 post
September 2024
(2)
2 posts
June 2024
(2)
2 posts
May 2024
(1)
1 post
March 2024
(1)
1 post
February 2024
(1)
1 post
January 2024
(1)
1 post
December 2023
(1)
1 post
November 2023
(1)
1 post
September 2023
(2)
2 posts
August 2023
(1)
1 post
July 2023
(4)
4 posts
June 2023
(2)
2 posts
May 2023
(2)
2 posts
April 2023
(1)
1 post
February 2023
(1)
1 post
January 2023
(1)
1 post
December 2022
(1)
1 post
October 2022
(1)
1 post
September 2022
(2)
2 posts
August 2022
(2)
2 posts
July 2022
(1)
1 post
June 2022
(1)
1 post
May 2022
(2)
2 posts
April 2022
(1)
1 post
March 2022
(1)
1 post
January 2022
(1)
1 post
December 2021
(2)
2 posts
October 2021
(3)
3 posts
September 2021
(1)
1 post
August 2021
(2)
2 posts
June 2021
(1)
1 post
May 2021
(1)
1 post
April 2021
(1)
1 post
February 2021
(1)
1 post
January 2021
(1)
1 post
December 2020
(1)
1 post
November 2020
(1)
1 post
October 2020
(1)
1 post
July 2020
(2)
2 posts
April 2020
(1)
1 post
March 2020
(1)
1 post
February 2020
(1)
1 post
January 2020
(1)
1 post
December 2019
(1)
1 post
October 2019
(1)
1 post
September 2019
(1)
1 post
August 2019
(3)
3 posts
July 2019
(2)
2 posts
Catalyst OrthoScience Names Carl O’Connell as President and CEO
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has named Carl...
bottom of page
